Literature DB >> 24270937

[Perioperative management of patients with hemophilia].

S Lison1, M Spannagl.   

Abstract

Hemophilia A and hemophilia B are X chromosome-linked congenital bleeding disorders caused by a deficiency or absence of activity of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B), which are graded in different degrees of severity (mild, moderate, severe). Depending on the severity patients may experience spontaneous bleeding episodes or will develop excessive bleeding in the context of injuries or surgery. Hemophilia should not be a contraindication for an invasive procedure; however, a number of conditions are required to provide successful surgery and an uncomplicated and safe postoperative course. This review provides an overview of hemophilia and the key biochemical laboratory and clinical aspects as well as possible specific and non-specific treatment options and addresses the special needs for the perioperative care of these patients.

Entities:  

Mesh:

Year:  2014        PMID: 24270937     DOI: 10.1007/s00101-013-2256-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  30 in total

1.  Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.

Authors:  G C White; F Rosendaal; L M Aledort; J M Lusher; C Rothschild; J Ingerslev
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

Review 2.  Dose and response in haemophilia--optimization of factor replacement therapy.

Authors:  Alok Srivastava
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

3.  Mild haemophilia: a disease with many faces and many unexpected pitfalls.

Authors:  K Peerlinck; M Jacquemin
Journal:  Haemophilia       Date:  2010-07       Impact factor: 4.287

Review 4.  Venous thromboembolic disease in patients with haemophilia.

Authors:  Cedric Hermans
Journal:  Thromb Res       Date:  2012-10       Impact factor: 3.944

Review 5.  Orthopaedic surgery of haemophilia in the 21st century: an overview.

Authors:  E C Rodriguez-Merchan
Journal:  Haemophilia       Date:  2002-05       Impact factor: 4.287

Review 6.  The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents.

Authors:  A Villar; V Jimenez-Yuste; M Quintana; F Hernandez-Navarro
Journal:  Haemophilia       Date:  2002-05       Impact factor: 4.287

Review 7.  Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses.

Authors:  Stephen Choi; Richard Brull
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

Review 8.  Haemophilia and thrombophilia: an unexpected association!

Authors:  Y Dargaud; S Meunier; C Negrier
Journal:  Haemophilia       Date:  2004-07       Impact factor: 4.287

Review 9.  [Congenital coagulopathies and coagulation factor inhibitors].

Authors:  J Oldenburg; M Barthels
Journal:  Hamostaseologie       Date:  2008-12       Impact factor: 1.778

10.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941

View more
  1 in total

1.  [Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus].

Authors:  Dong-Sheng Zhang; Jia-Wei Zheng; Chen-Ping Zhang; Zhi-Gang Cai; Long-Jiang Li; Gui-Qing Liao; Zheng-Jun Shang; Mo-Yi Sun; Zheng-Xue Han; Wei Shang; Jian Meng; Zhong-Cheng Gong; Sheng-Yun Huang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.